UTILISATION D'UNE EXPRESSION GENIQUE SPECIFIQUE DES CELLULES IMMUNITAIRES POUR LE PRONOSTIC DU CANCER DE LA PROSTATE ET LA PREDICTION DE LA SENSIBILITE A LA RADIOTHERAPIE
DECIPHER BIOSCIENCES, INC.;THE REGENTS OF THE UNIVERSITY OF MICHIGAN
发明人:
DAVICIONI, ELAI,ERHO, NICHOLAS GEORGE,LEHRER, JONATHAN,FENG, FELIX Y.,ZHAO, SHUANG G.
申请号：
CA3072061
公开号：
CA3072061A1
申请日:
2018.08.02
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
Methods, systems, and kits for the diagnosis, prognosis and the determination of cancer progression of prostate cancer in a subject are disclosed. In particular, the disclosure relates to the use of immune cell-specific gene expression in determining prognosis and identifying individuals in need of treatment for prostate cancer who will be responsive to radiation therapy.
